Part I: Behavioral and Biomedical Risk Factcors 1. The Effects of Tobacco Smoke on Cognition and the Brain Gary E. Swan. and Christina N. Lessov-Schlagger 2. Alcohol Consumption, Brain, and Neurocognition Francesco Panza, Vincenza Frisardi, Davide Seripa, Alberto Pilotto, and Vincenzo Solfrizzi 3. Activity and Neurocognitive Health in Older Adults Michelle C. Carlson and Vijay R. Varma 4. Hypertension, Blood Pressure, and Cognitive Functioning Merrill F. Elias, Amanda F. Goodell, and Michael A. Robbins 5. Effects of Cholesterol and N-3 Fatty Acids on Cognitive Functioning, Decline, and Dementia Matthew F. Muldoon and Sarah M. Conklin 6. Cognition in Diabetes and Pre-Diabetes Stages Augustina M.A. Brands, Esther van den Berg, Geert Jan, Biessels, and Roy P.C. Kessels 7. Neurocognitive Aspects of Obesity Kelly M. Stanek, Lindsay A. Miller, and John Gunstad. 8. Inflammation Anna L. Marsland 9. Homocysteine, Folic Acid, B Vitamins, and Cognitive Functioning Georgina E. Crichton, Michael A. Robbins, and Merrill, F. Elias 10. Resting and Stress-Reactive Cortisol Nida Ali, Vincent Corbo, Laura Copeland, amd Jens C. Pruessner Part II: Cardiovascular Disease and Interventions 11. Subclinical Cardiovascular Disease and Neurocognition Carrington Rice Wendell, and Shari R. Waldstein 12. Clinical Cardiovascular Disease Nathalie Stroobant, Merrill, F. Elias, and Amanda F. Goodell 13. Coronary Artery Bypass Surgery Patrick J. Smith, Joseph P. Mathew, and James A. Blumenthal 14. Heart Failure and Cognitive Function Ronald A. Cohen and Karin F. Hoth Part III: Dementia and Stroke 15. Cardiovascular Risk Factors and Dementia Chengxuan Qiu and Laura Fratiglioni 16. Vascular Cognitive Impairment Jose G. Merino and Vladimir Hachinski 17. White Matter Disease, Stroke, and the Heterogeneity of Vascular Dementia Catherine C. Price, Peter Nguyen, Melissa Lamar, and David J. Libon 18. Structural Brain Mechanisms and Dementia Samuel N. Lockhart and Charles DeCarli
Neuropsychology of Cardiovascular Diseaseby Merrill F. Elias
Pub. Date: 01/28/2001
Publisher: Taylor & Francis
Cardiovascular disease, the leading cause of morbidity and mortality in the United States and many other countries, confers substantial risk for cerebrovascular events, such as stroke and vascular dementia. The neuropsychological sequelae of such conditions are well documented and can have a devastating impact on individuals' quality of life. However, prior to the
Cardiovascular disease, the leading cause of morbidity and mortality in the United States and many other countries, confers substantial risk for cerebrovascular events, such as stroke and vascular dementia. The neuropsychological sequelae of such conditions are well documented and can have a devastating impact on individuals' quality of life. However, prior to the development of overt cerebrovascular complications, persons with cardiovascular disease or its risk factors may display mild to severe neuropsychological difficulties. Medical and surgical treatments for cardiovascular disease have also been found to affect neuropsychological function.
This landmark volume offers the first comprehensive overview of the neuropsychological consequences of cardiovascular disease, tracking its natural history, epidemiology, and treatments. It encourages researchers and clinicians to consider all relevant facets of vascular disease processes in their evaluation, study, and treatment of affected patients and indicates a need for primary and secondary prevention efforts. Neuropsychology of Cardiovascular Disease will be welcomed as an invaluable resource by neuropsychologists, specialists in behavioral medicine, neurologists, cardiologists, epidemiologists, gerontologists, and many other health professionals whose work brings them into contact with these challenging patients.
- Taylor & Francis
- Publication date:
- Product dimensions:
- 6.10(w) x 9.10(h) x 1.10(d)
Table of Contents
Most Helpful Customer Reviews
See all customer reviews